For reference: 4 mg · 1 mL. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a factor of ten,…
All questions
Newest first. 5.2k questions across 107 tags.
The particulars: 40 units · 2.5 mg/mL. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than discover a problem…
The particulars: deamidation · survodutide · minus 80 °C. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I…
The case in front of me: GGPeps · Guangzhou · the United States. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with…
I am asking about the protocol logic rather than about my own case specifically. I want to understand what this actually establishes, as opposed to what it is being…
For reference: 98.2% · a wide-pore C18 column · a GLP-1 receptor agonist. I want to understand what this actually establishes, as opposed to what it is being used to…
The particulars: AST · ecnoglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules, not…
The lane and the lead time matter as much as the material for what I am doing. I would rather understand the derivation than memorise the outcome. Two people I asked…
Concretely: FGP · Shanghai Sigma-Audley. Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints are…
This matters because it predicts what a related molecule should do. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me…
What I am working with: lipase · two weeks · semaglutide. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
Setup, so nobody has to ask: FGP · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the source.…
Details up front: 99.4% · retatrutide · GL Biochem. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me…
Details up front: phosphate-buffered diluent · twenty-one days. I would like to understand the steps well enough to explain them to someone else. I have access to a…
Details up front: a GLP-1 receptor agonist · ESSENCE. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
The specifics, since they change the answer: Changsha · Ireland. This is presented as though it settles something, and I am not convinced it does. I have two…
Numbers first: 8 mg · 5 mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would rather learn…
Setup, so nobody has to ask: albumin-to-creatinine ratio · orforglipron. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if…
Concretely: SURMOUNT-OSA · tirzepatide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
The specifics, since they change the answer: an insulated cool box · tirzepatide. I want to decide this in advance so that I am not deciding it under pressure later.…
Details up front: Wuhan · Japan. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change…
Concretely: survodutide · twelve weeks · 25 °C. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically,…
What I have: HJ · tirzepatide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
Concretely: ecnoglutide · 8 mg/mL. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write down, so…